# Alembic Pharmaceuticals Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/alembic-pharmaceuticals-limited/922eba08-7d55-42d2-9d7e-d116c041af25

> Inspection records and compliance data for Alembic Pharmaceuticals Limited in Panchmahal, None. Access full analysis and detailed observations.

---

## Details

- Name: Alembic Pharmaceuticals Limited
- FEI Number: 3004956904
- City: Panchmahal
- State: None
- Country Name: India
- Address Line 1: Formulation Division, Village Panelav, P.O. Tajpura, Near Baska, Taluka Halol
- Zip Code: None
- Facility Type: Drug Manufacturer
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Alembic Pharmaceuticals Limited - Unknown Date](https://www.globalkeysolutions.net/records/483/alembic-pharmaceuticals-limited/089e0b76-b314-449b-8ee8-280ef4484a66) — source: FDA, date: Invalid Date
- [FDA Inspection 1242965 - Alembic Pharmaceuticals Limited - 2024-07-26](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/6cefe93c-2291-4bee-9e70-e83652685e8b) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2024
- [FDA Inspection 1123365 - Alembic Pharmaceuticals Limited - 2020-03-13](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/8c98841b-b583-49f5-a0b0-8674bd53e6f3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2020
- [FDA Inspection 1069852 - Alembic Pharmaceuticals Limited - 2018-10-26](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/134bf1bb-402c-44ff-bf59-563a7b796577) — classification: No Action Indicated (NAI), source: FDA, date: October 26, 2018
- [483 - Alembic Pharmaceuticals Limited - 2018-03-20](https://www.globalkeysolutions.net/records/483/alembic-pharmaceuticals-limited/a81be92f-aa80-44d2-a123-2cd68fca1582) — source: FDA, date: March 20, 2018
- [FDA Inspection 1048097 - Alembic Pharmaceuticals Limited - 2018-03-20](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/4b3044f7-5634-4ca9-8f1d-9dd3f62ede6a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2018
- [483 - Alembic Pharmaceuticals Limited - 2016-03-25](https://www.globalkeysolutions.net/records/483/alembic-pharmaceuticals-limited/b5435c4b-1323-4172-9f87-3079d507645c) — source: FDA, date: March 25, 2016
- [FDA Inspection 967744 - Alembic Pharmaceuticals Limited - 2016-03-25](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/34cffa60-d5fb-4d35-a11a-b2dfc1fc791b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016
- [FDA Inspection 921484 - Alembic Pharmaceuticals Limited - 2015-02-20](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/caae2138-96dd-4c0a-ad0e-3db7d7425172) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2015
- [FDA Inspection 797144 - Alembic Pharmaceuticals Limited - 2012-08-30](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/32d8a3c8-6212-4969-b407-84e106d14689) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2012
- [FDA Inspection 672515 - Alembic Pharmaceuticals Limited - 2010-05-15](https://www.globalkeysolutions.net/records/fda_inspections/alembic-pharmaceuticals-limited/7ed68a77-fb7f-48a5-9602-a6f0fb28de5b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2010

## Related Companies

- [Pharbil Waltrop Gmbh](https://www.globalkeysolutions.net/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c)
- [Optikem International, Inc.](https://www.globalkeysolutions.net/companies/optikem-international-inc/6d89f8c9-2ba5-4826-a8e3-e71a5a10fb3e)
- [Milbar Laboratories, Inc.](https://www.globalkeysolutions.net/companies/milbar-laboratories-inc/f2d60bc9-405c-493a-a422-7a93d38d883b)
- [InvaGen Pharmaceuticals, Inc.](https://www.globalkeysolutions.net/companies/invagen-pharmaceuticals-inc/8841516b-25bb-463f-9666-11b69458c306)
- [Blaine Labs Inc](https://www.globalkeysolutions.net/companies/blaine-labs-inc/9b08b501-8f11-452d-914e-3f5339cbed81)
- [Episciences Inc](https://www.globalkeysolutions.net/companies/episciences-inc/db9de422-87ad-44ad-bf37-a1cd35fdb978)
- [Wasatch Product Development, LLC](https://www.globalkeysolutions.net/companies/wasatch-product-development-llc/3545661f-a68f-404a-895d-c00555648648)
- [Lewiston Feed & Produce Company](https://www.globalkeysolutions.net/companies/lewiston-feed-produce-company/17157872-1c9b-4422-8356-e27e553075cd)
- [Hahnemann Laboratories, Inc.,  dba Alpine Pharmaceuticals](https://www.globalkeysolutions.net/companies/hahnemann-laboratories-inc-dba-alpine-pharmaceuticals/449cf2ad-b13b-4c49-ae83-2f8fac91ae20)
- [Grifols Biologicals LLC](https://www.globalkeysolutions.net/companies/grifols-biologicals-llc/206a08df-1e93-4280-b926-83661b2bb985)

## Related Officers

- [Compliance Officer / Investigator](https://www.globalkeysolutions.net/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)
- [Jeffrey Meng Program](https://www.globalkeysolutions.net/people/jeffrey-meng-program/6d5885d8-f0e0-4279-9066-920c69d3115e)
- [Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre](https://www.globalkeysolutions.net/people/jessica-l-pressley/2c190e50-81bd-4015-95f0-7177beb363bd)
- [investigator](https://www.globalkeysolutions.net/people/shirshendu-k-deb/d8e51b5d-e39c-46c5-893d-b01261babec4)
- [Cynthia Jim](https://www.globalkeysolutions.net/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)